|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Epilepsy in Adults
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Leukemia
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Chronic Lymphocytic Leukemia
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Heart Failure
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Waldenström Macroglobulinemia
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Neurogenic Dysphagia
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Kidney Itch: CKD-associated pruritus: under-recognized and under-treated
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Dementia and Augmentative and Alternative Communication
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facs: Non-Small-Cell Lung Cancer
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Dermatological Nursing
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts for Patients: Thrombotic Thrombocytopenic Purpura
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Early Hearing Detection and Intervention
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Myelofibrosis
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: The Essentials of Cytopathology
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Molecular Profiling in Solid Tumors
- [Fast Facts 1]
-
Karger | 2022.01.01
-
40,000¿ø
|
| |
40,000¿ø
+ 2,000P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Endometrial Cancer
- [Fast Facts 1]
-
Karger | 2022.01.01
-
355,000¿ø
|
| |
355,000¿ø
+ 17,750P (5%)
|
|
-
(¼¿ï½Ã °³²±¸ »ï¼º·Î 512 ±âÁØ)
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Cholangiocarcinoma
- [Fast Facts 1]
-
Denlinger Àú | Karger | 2021.01.01
-
-
Áö±Ý ÁÖ¹®Çϸé, 3ÀÏ À̳» Ãâ°í¿¹Á¤
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|
|
|
|
|
-
-
Fast Facts: Long-Chain Fatty Acid Oxidation Disorders
- [Fast Facts 1]
-
Burton Àú | Karger | 2021.01.01
-
-
Áö±Ý ÁÖ¹®Çϸé, 3ÀÏ À̳» Ãâ°í¿¹Á¤
-
±â´ëÁö¼ö 0
I
³»¿ë 0
I
Àç¹Ì 0
I
ÆíÁý/µðÀÚÀÎ 0
-
|
|
|
|
|
|